NYSE:CVS - CVS Health Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $91.69
Forecasted Upside: 7.73 %
Number of Analysts: 12
Breakdown:
0 Sell Ratings
3 Hold Ratings
8 Buy Ratings
1 Strong Buy Ratings

^$85.11 As of 05/7/2021 01:00 AM ET

▲ +1.41 (1.68%)

1 month | 3 months | 12 months

Get New CVS Health Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for CVS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CVS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$91.69

▲ +7.73% Upside Potential

This price target is based on 12 analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is $91.69, with a high forecast of $101.00 and a low forecast of $76.00. The average price target represents a 7.73% upside from the last price of $85.11.

Buy

The current consensus among 12 contributing investment analysts is to buy stock in CVS Health. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

1 strong buy ratings
17 buy ratings
8 hold ratings
0 sell ratings

Ratings as of

11/15/2019

2 strong buy ratings
17 buy ratings
7 hold ratings
0 sell ratings

Ratings as of

2/13/2020

2 strong buy ratings
15 buy ratings
2 hold ratings
0 sell ratings

Ratings as of

5/13/2020

2 strong buy ratings
13 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

8/11/2020

2 strong buy ratings
11 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

11/9/2020

1 strong buy ratings
12 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

2/7/2021

0 strong buy ratings
12 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

4/8/2021

1 strong buy ratings
8 buy ratings
3 hold ratings
0 sell ratings

Ratings as of

5/8/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
5/6/2021	Credit Suisse Group	Boost Price Target	Outperform	$91.00 ➝ $100.00	Low	i
5/6/2021	BMO Capital Markets	Boost Price Target	Market Perform	$82.00 ➝ $90.00	Low	i
5/5/2021	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Boost Price Target		$83.00 ➝ $98.00	Low	i
5/5/2021	Citigroup	Boost Price Target		$83.00 ➝ $98.00	Medium	i
5/5/2021	Jefferies Financial Group	Boost Price Target	Buy	$90.00 ➝ $95.00	Medium	i
5/5/2021	Raymond James	Boost Price Target	Strong-Buy	$90.00 ➝ $95.00	High	i
5/5/2021	Royal Bank of Canada	Boost Price Target	Outperform	$80.00 ➝ $91.00	High	i
4/20/2021	Morgan Stanley	Boost Price Target	Overweight	$86.00 ➝ $92.00	Low	i
4/20/2021	Truist Securities	Boost Price Target	Buy	$80.00 ➝ $88.00	Low	i
4/14/2021	Truist	Boost Price Target		$80.00 ➝ $88.00	Medium	i
4/14/2021	Truist Securities	Boost Price Target	Buy	$80.00 ➝ $88.00	Low	i
4/14/2021	Morgan Stanley	Boost Price Target	Overweight	$86.00 ➝ $92.00	Medium	i
3/23/2021	Guggenheim	Reiterated Rating	Buy ➝ Neutral		Medium	i
3/17/2021	Guggenheim	Downgrade	Buy ➝ Neutral		Low	i
1/8/2021	Jefferies Financial Group	Upgrade	Hold ➝ Buy	$90.00	Low	i
12/14/2020	SVB Leerink	Boost Price Target	Market Perform	$73.00 ➝ $80.00	High	i Rating by D. Ha at SVB Leerink LLC
11/11/2020	Piper Sandler	Boost Price Target	Overweight	$72.00 ➝ $76.00	Low	i
11/9/2020	Cantor Fitzgerald	Reiterated Rating	Overweight		High	i Rating by S. Halper at Cantor Fitzgerald
11/9/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$104.00 ➝ $101.00	High	i
9/17/2020	Piper Sandler	Initiated Coverage	Overweight	$72.00 ➝ $72.00	Medium	i
8/7/2020	Credit Suisse Group	Boost Price Target	Outperform	$75.00 ➝ $90.00	Medium	i Rating by A.J. Rice at Credit Suisse Group AG
8/6/2020	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$109.00 ➝ $104.00	Low	i
8/6/2020	SVB Leerink	Boost Price Target	Market Perform	$72.00 ➝ $73.00	Low	i Rating by D. Ha at SVB Leerink LLC
7/9/2020	Royal Bank of Canada	Reiterated Rating	Buy		Low	i
7/1/2020	SVB Leerink	Initiated Coverage	Market Perform	$72.00	Low	i Rating by S. Davis at SVB Leerink LLC
5/14/2020	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$75.00	Low	i Rating by Erin Wright at Credit Suisse Group AG
5/8/2020	Credit Suisse Group	Reiterated Rating	Hold		Low	i Rating by Erin Wright at Credit Suisse Group AG
5/7/2020	Robert W. Baird	Boost Price Target	Neutral	$62.00 ➝ $66.00	Low	i
5/7/2020	UBS Group	Lower Price Target	Buy	$85.00 ➝ $79.00	Low	i
5/7/2020	Citigroup	Lower Price Target	Buy	$86.00 ➝ $75.00	Low	i
5/7/2020	Morgan Stanley	Boost Price Target	Overweight	$71.00 ➝ $77.00	Low	i
5/6/2020	Royal Bank of Canada	Reiterated Rating	Buy	$77.00	High	i
5/6/2020	Oppenheimer	Reiterated Rating	Hold		High	i Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
5/4/2020	JPMorgan Chase & Co.	Lower Price Target	Overweight	$97.00 ➝ $94.00	Low	i
4/24/2020	Tigress Financial	Reiterated Rating	Buy		Medium	i Rating by Ivan Feinseth at Tigress Financial
4/13/2020	Morgan Stanley	Boost Price Target	Overweight	$70.00 ➝ $71.00	Low	i
4/13/2020	SunTrust Banks	Lower Price Target	Buy	$90.00 ➝ $80.00	Medium	i
4/12/2020	Royal Bank of Canada	Reiterated Rating	Buy	$77.00	High	i
3/27/2020	Morgan Stanley	Lower Price Target	Overweight	$88.00 ➝ $70.00	Medium	i
3/27/2020	Robert W. Baird	Lower Price Target	Neutral	$73.00 ➝ $62.00	Medium	i
3/25/2020	Royal Bank of Canada	Lower Price Target		$85.00 ➝ $81.00	Medium	i Rating by Anton Hie at Royal Bank of Canada
3/19/2020	Credit Suisse Group	Reiterated Rating	Hold	$75.00	Medium	i Rating by Erin Wright at Credit Suisse Group AG
2/18/2020	Deutsche Bank Aktiengesellschaft	Boost Price Target	Buy	$97.00 ➝ $109.00	Low	i
2/14/2020	Citigroup	Boost Price Target	Buy	$83.00 ➝ $86.00	Medium	i
2/13/2020	Robert W. Baird	Boost Price Target	Neutral	$70.00 ➝ $73.00	Medium	i
2/13/2020	UBS Group	Boost Price Target	Buy	$78.00 ➝ $85.00	Medium	i
2/13/2020	Cantor Fitzgerald	Boost Price Target	Overweight	$85.00 ➝ $90.00	Medium	i
2/12/2020	Oppenheimer	Initiated Coverage	Hold		Medium	i Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
2/12/2020	Cfra	Boost Price Target	Strong-Buy	$85.00 ➝ $86.00	Medium	i
12/19/2019	JPMorgan Chase & Co.	Boost Price Target	Overweight	$88.00 ➝ $97.00	Low	i
12/4/2019	Raymond James	Reiterated Rating	Strong-Buy	$80.00 ➝ $90.00	Low	i
11/8/2019	Mizuho	Boost Price Target	Buy	$71.00 ➝ $82.00	Low	i Rating by Ann Hynes at Mizuho
11/7/2019	UBS Group	Reiterated Rating	Buy	$78.00 ➝ $78.00	Low	i
11/7/2019	Raymond James	Boost Price Target	Strong-Buy	$75.00 ➝ $80.00	Low	i
11/7/2019	SunTrust Banks	Boost Price Target	Buy	$85.00	Low	i
11/7/2019	Citigroup	Boost Price Target	Buy	$72.00 ➝ $83.00	Low	i
10/21/2019	Cowen	Set Price Target	Buy	$76.00	Low	i Rating by Charles Rhyee at Cowen Inc
9/27/2019	Royal Bank of Canada	Initiated Coverage	Outperform	$85.00	Low	i
9/26/2019	Morgan Stanley	Boost Price Target	Overweight	$74.00 ➝ $77.00	Medium	i Rating by Ricky Goldwasser at Morgan Stanley
9/12/2019	Bank of America	Boost Price Target	Buy	$72.00 ➝ $75.00	Low	i
9/12/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$91.00	Medium	i
8/27/2019	Cowen	Reiterated Rating	Outperform	$69.00 ➝ $76.00	Medium	i
8/11/2019	Morgan Stanley	Reiterated Rating	Buy	$74.00	Low	i Rating by Ricky Goldwasser at Morgan Stanley
8/8/2019	Citigroup	Boost Price Target	Buy	$68.00 ➝ $72.00	Medium	i Rating by Ralph Giacobbe at Citigroup Inc.
8/7/2019	Evercore ISI	Set Price Target	Buy	$63.00	Low	i Rating by Ross Muken at Evercore ISI
6/5/2019	Mizuho	Set Price Target	Buy	$71.00	Medium	i Rating by Ann Hynes at Mizuho
6/5/2019	Standpoint Research	Upgrade	Hold ➝ Buy		High	i
5/3/2019	BMO Capital Markets	Set Price Target	Hold	$63.00	Low	i Rating by Matthew Borsch at BMO Capital Markets
5/2/2019	Citigroup	Set Price Target	Buy	$74.00	Low	i Rating by Ralph Giacobbe at Citigroup Inc.
5/2/2019	UBS Group	Lower Price Target	Sell ➝ Sell	$74.00 ➝ $67.00	Low	i
5/1/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$80.00	Low	i Rating by S. Halper at Cantor Fitzgerald
4/29/2019	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$92.00 ➝ $74.00	Low	i Rating by Ricky Goldwasser at Morgan Stanley
4/29/2019	Credit Suisse Group	Downgrade	Outperform ➝ Neutral	$73.00 ➝ $61.00	Medium	i
4/21/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$80.00	Low	i Rating by S. Halper at Cantor Fitzgerald
4/18/2019	Raymond James	Lower Price Target	Strong-Buy ➝ Strong-Buy	$90.00 ➝ $75.00	Low	i
4/18/2019	Guggenheim	Initiated Coverage	Buy ➝ Buy	$90.00 ➝ $75.00	Low	i
4/15/2019	CIBC	Reiterated Rating	Outperform ➝ Market Perform		Low	i
4/15/2019	Oppenheimer	Downgrade	Outperform ➝ Market Perform		Low	i
4/11/2019	Barclays	Set Price Target	Buy	$73.00	High	i Rating by Steven Valiquette at Barclays PLC
4/10/2019	BMO Capital Markets	Initiated Coverage	Outperform	$58.00	Medium	i
4/10/2019	SunTrust Banks	Lower Price Target		$85.00 ➝ $65.00	Low	i
4/10/2019	Bank of America	Reiterated Rating	Buy	$82.00 ➝ $74.00	Low	i
3/12/2019	Sanford C. Bernstein	Initiated Coverage	Outperform ➝ Outperform	$76.00	High	i
3/6/2019	Citigroup	Lower Price Target	Buy ➝ Buy	$94.00 ➝ $68.00	Medium	i
2/25/2019	Argus	Lower Price Target	Buy ➝ Positive	$100.00 ➝ $80.00	Low	i
2/22/2019	Morgan Stanley	Set Price Target	Buy	$92.00	Low	i Rating by Ricky Goldwasser at Morgan Stanley
2/21/2019	SunTrust Banks	Lower Price Target	Buy	$85.00	Medium	i
2/21/2019	UBS Group	Lower Price Target	Buy ➝ Buy	$75.00 ➝ $74.00	High	i
2/21/2019	Loop Capital	Lower Price Target	In-Line ➝ Hold	$68.00	High	i Rating by Andrew Wolf at Loop Capital
2/21/2019	JPMorgan Chase & Co.	Reiterated Rating	Overweight	$91.00	High	i
2/21/2019	Cantor Fitzgerald	Reiterated Rating	Overweight	$80.00	High	i Rating by S. Halper at Cantor Fitzgerald
2/20/2019	Wells Fargo & Company	Downgrade	Outperform ➝ Market Perform	$104.00 ➝ $68.00	High	i
1/17/2019	UBS Group	Initiated Coverage	Buy ➝ Buy	$75.00	Low	i
1/3/2019	Cantor Fitzgerald	Reiterated Rating	Buy	$96.00	Low	i Rating by S. Halper at Cantor Fitzgerald
1/3/2019	Bank of America	Reiterated Rating	Buy	$92.00	Low	i
12/18/2018	Barclays	Initiated Coverage	Overweight ➝ Overweight	$91.00	Medium	i
12/11/2018	SVB Leerink	Initiated Coverage	Outperform		Medium	i Rating by David Larsen at SVB Leerink LLC
12/2/2018	Cantor Fitzgerald	Initiated Coverage	Overweight	$96.00 ➝ $77.84	Low	i Rating by S. Halper at Cantor Fitzgerald
11/29/2018	The Goldman Sachs Group	Reiterated Rating	Neutral ➝ Neutral	$87.00	Low	i
11/28/2018	Evercore ISI	Initiated Coverage	Outperform ➝ Outperform	$89.00	Low	i
11/28/2018	Loop Capital	Set Price Target	Hold	$80.00	High	i Rating by Andrew Wolf at Loop Capital
11/27/2018	Wells Fargo & Company	Boost Price Target	Outperform	$98.00 ➝ $104.00	Medium	i
11/26/2018	Cantor Fitzgerald	Initiated Coverage	Overweight	$96.00	High	i Rating by S. Halper at Cantor Fitzgerald
11/13/2018	Argus	Boost Price Target	Buy	$100.00	Low	i
11/9/2018	Loop Capital	Set Price Target	Hold	$70.00 ➝ $80.00	N/A	i Rating by Andrew Wolf at Loop Capital
11/8/2018	SVB Leerink	Boost Price Target	Outperform ➝ Positive	$85.00 ➝ $95.00	Medium	i Rating by David Larsen at SVB Leerink LLC
11/7/2018	Morgan Stanley	Set Price Target	Buy	$80.00 ➝ $100.00	Low	i Rating by Ricky Goldwasser at Morgan Stanley
11/7/2018	Royal Bank of Canada	Set Price Target	Buy	$100.00	Medium	i Rating by George Hill at Royal Bank of Canada
10/26/2018	Tigress Financial	Reiterated Rating	Buy		Low	i
10/25/2018	Wolfe Research	Initiated Coverage	Peer Perform ➝ Peer Perform		Low	i
10/23/2018	Royal Bank of Canada	Set Price Target	Buy	$99.00	Low	i Rating by George Hill at Royal Bank of Canada
9/18/2018	Royal Bank of Canada	Boost Price Target	Outperform	$101.00	Medium	i Rating by George Hill at Royal Bank of Canada
9/17/2018	Bank of America	Boost Price Target	Buy	$86.00 ➝ $90.00	Medium	i
8/9/2018	SVB Leerink	Set Price Target	Outperform	$85.00 ➝ $80.00	Low	i Rating by David Larsen at SVB Leerink LLC
8/8/2018	Royal Bank of Canada	Reiterated Rating	Positive ➝ Buy	$90.00	Low	i Rating by George Hill at Royal Bank of Canada
7/9/2018	Citigroup	Reiterated Rating	Neutral ➝ Buy	$81.00	Low	i Rating by Alvin Concepcion at Citigroup Inc.
7/3/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$88.00 ➝ $80.00	Low	i Rating by Ricky Goldwasser at Morgan Stanley
6/30/2018	Mizuho	Reiterated Rating	Buy		Low	i Rating by Ann Hynes at Mizuho
6/29/2018	Royal Bank of Canada	Lower Price Target	Outperform	$84.00	Medium	i Rating by George Hill at Royal Bank of Canada
6/13/2018	Mizuho	Set Price Target	Buy	$95.00	High	i Rating by Ann Hynes at Mizuho
5/7/2018	Loop Capital	Set Price Target	Hold	$68.00	Medium	i Rating by Andrew Wolf at Loop Capital
4/11/2018	Bank of America	Lower Price Target	Buy ➝ Buy	$91.00 ➝ $88.00	Low	i Rating by Michael Cherny at Bank of America Co.
4/10/2018	SVB Leerink	Set Price Target	Buy	$85.00	Low	i Rating by David Larsen at SVB Leerink LLC
2/27/2018	Bank of America	Initiated Coverage	Buy ➝ Buy	$91.00	Low	i
2/13/2018	Citigroup	Set Price Target	Neutral ➝ Neutral	$80.00 ➝ $77.00	Low	i Rating by Alvin Concepcion at Citigroup Inc.
2/9/2018	SVB Leerink	Set Price Target	Outperform ➝ Buy	$90.00 ➝ $85.00	Low	i Rating by David Larsen at SVB Leerink LLC
2/9/2018	Robert W. Baird	Lower Price Target	Neutral ➝ Neutral	$85.00 ➝ $80.00	Low	i Rating by Eric Coldwell at Robert W. Baird
2/9/2018	Needham & Company LLC	Set Price Target	Strong-Buy ➝ Buy	$100.00 ➝ $98.00	Medium	i Rating by Kevin Caliendo at Needham & Company LLC
2/8/2018	Royal Bank of Canada	Set Price Target	Buy	$89.00	Medium	i Rating by George Hill at Royal Bank of Canada
1/30/2018	Needham & Company LLC	Upgrade	Buy ➝ Strong-Buy	$88.00 ➝ $100.00	High	i Rating by Kevin Caliendo at Needham & Company LLC
1/24/2018	Mizuho	Set Price Target	Buy	$95.00	Low	i Rating by Ann Hynes at Mizuho
1/18/2018	Cowen	Reiterated Rating	Outperform	$81.00 ➝ $99.00	Low	i Rating by Charles Rhyee at Cowen Inc
1/8/2018	SVB Leerink	Boost Price Target	Outperform ➝ Outperform	$82.00 ➝ $90.00	Low	i Rating by David Larsen at SVB Leerink LLC
1/5/2018	SunTrust Banks	Boost Price Target	Buy	$90.00	High	i Rating by David S Macdonald at SunTrust Banks, Inc.
1/5/2018	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$88.00	High	i
1/4/2018	Raymond James	Upgrade	Outperform ➝ Strong-Buy	$90.00	High	i
1/4/2018	UBS Group	Upgrade	Outperform ➝ Strong-Buy		High	i
1/2/2018	Needham & Company LLC	Boost Price Target	Buy	$85.00 ➝ $88.00	Medium	i Rating by Kevin Caliendo at Needham & Company LLC
12/26/2017	Tigress Financial	Reiterated Rating	Buy		Low	i
12/5/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy ➝ Hold		Medium	i
12/4/2017	Raymond James	Reiterated Rating	Buy		Low	i
12/4/2017	Royal Bank of Canada	Set Price Target	Buy	$95.00	Low	i Rating by George Hill at Royal Bank of Canada
12/4/2017	Robert W. Baird	Set Price Target	Hold	$77.00	Medium	i Rating by Eric Coldwell at Robert W. Baird
12/4/2017	Jefferies Financial Group	Set Price Target	Hold	$76.00	Medium	i Rating by Brian Tanquilut at Jefferies Financial Group Inc.
12/4/2017	Loop Capital	Set Price Target	Hold	$73.00	Medium	i Rating by Andrew Wolf at Loop Capital
12/4/2017	Citigroup	Set Price Target	Hold	$76.00	Medium	i Rating by Alvin Concepcion at Citigroup Inc.
12/4/2017	SVB Leerink	Set Price Target	Buy	$85.00	High	i Rating by David Larsen at SVB Leerink LLC
12/4/2017	Needham & Company LLC	Boost Price Target	Buy	$79.00 ➝ $85.00	High	i Rating by Kevin Caliendo at Needham & Company LLC
12/4/2017	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy ➝ Buy	$69.00 ➝ $90.00	High	i
11/10/2017	Needham & Company LLC	Upgrade	Hold ➝ Buy	$69.02 ➝ $79.00	N/A	i Rating by Kevin Caliendo at Needham & Company LLC
11/7/2017	Loop Capital	Lower Price Target	Hold	$83.00 ➝ $73.00	N/A	i Rating by Andrew Wolf at Loop Capital
11/7/2017	Jefferies Financial Group	Lower Price Target	Hold	$86.00 ➝ $76.00	N/A	i Rating by Brian Tanquilut at Jefferies Financial Group Inc.
11/7/2017	SVB Leerink	Reiterated Rating	Hold ➝ Outperform	$90.00 ➝ $85.00	N/A	i Rating by David Larsen at SVB Leerink LLC
11/3/2017	Citigroup	Lower Price Target	Neutral	$87.00 ➝ $74.00	N/A	i
10/29/2017	Cowen	Set Price Target	Buy	$86.00	N/A	i Rating by Charles Rhyee at Cowen Inc
10/27/2017	Loop Capital	Reiterated Rating	Hold		N/A	i Rating by Andrew Wolf at Loop Capital
10/27/2017	Robert W. Baird	Reiterated Rating	Hold	$77.00	N/A	i
10/24/2017	Mizuho	Set Price Target	Buy	$90.00	N/A	i
10/18/2017	Jefferies Financial Group	Set Price Target	Hold	$86.00	N/A	i Rating by Brian Tanquilut at Jefferies Financial Group Inc.
10/12/2017	SunTrust Banks	Set Price Target	Buy	$85.00	N/A	i
10/12/2017	Needham & Company LLC	Reiterated Rating	Hold		N/A	i Rating by Kevin Caliendo at Needham & Company LLC
10/9/2017	Oppenheimer	Reiterated Rating	Buy	$95.00	N/A	i
9/19/2017	Royal Bank of Canada	Initiated Coverage	Outperform ➝ Outperform	$95.00	Low	i
9/15/2017	Jefferies Financial Group	Boost Price Target	Hold ➝ Hold	$82.00 ➝ $86.00	Medium	i Rating by Brian Tanquilut at Jefferies Financial Group Inc.
9/10/2017	Needham & Company LLC	Reiterated Rating	Hold		Low	i Rating by Kevin Caliendo at Needham & Company LLC
8/24/2017	Loop Capital	Initiated Coverage	Hold ➝ Hold	$83.00	Low	i
8/17/2017	Citigroup	Lower Price Target	Neutral	$88.00 ➝ $87.00	Low	i
8/14/2017	Robert W. Baird	Reiterated Rating	Outperform	$90.00	Low	i
8/14/2017	Wolfe Research	Downgrade	Outperform ➝ Market Perform	$89.00 ➝ $82.00	Low	i
7/14/2017	Jefferies Financial Group	Reiterated Rating	Hold	$82.00	Low	i Rating by Brian Tanquilut at Jefferies Financial Group Inc.
7/3/2017	Guggenheim	Reiterated Rating	Buy		Low	i
6/27/2017	Needham & Company LLC	Initiated Coverage	Hold ➝ Hold		Low	i
6/27/2017	SVB Leerink	Set Price Target	Buy	$90.00	N/A	i Rating by David Larsen at SVB Leerink LLC
6/13/2017	Cowen	Reiterated Rating	Outperform	$86.00	Low	i
6/9/2017	Jefferies Financial Group	Reiterated Rating	Hold	$82.00	Low	i Rating by Brian Tanquilut at Jefferies Financial Group Inc.
5/3/2017	Evercore ISI	Reiterated Rating	Outperform	$87.00 ➝ $88.00	Low	i
4/27/2017	Tigress Financial	Initiated Coverage	Buy ➝ Buy		Low	i
4/4/2017	UBS Group	Reiterated Rating	Buy	$89.00 ➝ $88.00	N/A	i Rating by Michael Cherny at UBS Group AG
4/1/2017	Jefferies Financial Group	Set Price Target	Hold	$82.00	Low	i Rating by Brian Tanquilut at Jefferies Financial Group Inc.
3/28/2017	Guggenheim	Reiterated Rating	Buy	$90.00	Low	i
3/18/2017	SVB Leerink	Set Price Target	Buy	$90.00	Low	i Rating by David Larsen at SVB Leerink LLC
2/28/2017	Bank of America	Reiterated Rating	Buy	$106.67	N/A	i
2/16/2017	UBS Group	Reiterated Rating	Buy	$88.50 ➝ $89.00	N/A	i Rating by Michael Cherny at UBS Group AG
2/11/2017	SVB Leerink	Set Price Target	Buy	$90.00	N/A	i Rating by David Larsen at SVB Leerink LLC
2/10/2017	UBS Group	Set Price Target	Buy	$89.00	N/A	i Rating by Michael Cherny at UBS Group AG
2/9/2017	Evercore ISI	Lower Price Target	Buy	$91.50 ➝ $84.00	N/A	i
2/8/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Hold	$88.00	N/A	i
2/6/2017	Atlantic Securities	Downgrade	Overweight ➝ Neutral	$84.00	N/A	i
2/6/2017	Guggenheim	Reiterated Rating	Buy	$90.00	N/A	i
2/4/2017	UBS Group	Set Price Target	Buy	$89.00	N/A	i Rating by Michael Cherny at UBS Group AG
2/2/2017	Robert W. Baird	Downgrade	Outperform ➝ Neutral	$86.00 ➝ $77.00	N/A	i
12/28/2016	Guggenheim	Reiterated Rating	Buy	$90.00	N/A	i
12/19/2016	Credit Suisse Group	Reiterated Rating	Buy		N/A	i
12/18/2016	Oppenheimer	Set Price Target	Buy	$88.00	N/A	i Rating by Mohan Naidu at Oppenheimer Holdings Inc.
12/13/2016	Guggenheim	Reiterated Rating	Buy	$90.00	N/A	i
12/12/2016	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$122.00 ➝ $82.00	N/A	i
11/10/2016	Argus	Reiterated Rating	Buy	$120.00 ➝ $85.00	N/A	i
11/9/2016	Barclays	Reiterated Rating	Buy	$85.00	N/A	i
11/9/2016	SVB Leerink	Reiterated Rating	Buy	$105.00	N/A	i Rating by David Larsen at SVB Leerink LLC
11/9/2016	Mizuho	Boost Price Target	Buy	$90.00 ➝ $111.00	N/A	i Rating by Ann Hynes at Mizuho
11/8/2016	Guggenheim	Reiterated Rating	Buy	$115.00 ➝ $90.00	N/A	i
10/18/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Hold	$108.00 ➝ $99.00	N/A	i Rating by George Hill at Deutsche Bank Aktiengesellschaft
10/5/2016	UBS Group	Initiated Coverage	Buy	$107.00	N/A	i
10/4/2016	Credit Suisse Group	Reiterated Rating	Outperform	$115.00 ➝ $110.00	N/A	i Rating by Robert Willoughby at Credit Suisse Group AG
10/3/2016	Robert W. Baird	Lower Price Target	Outperform	$114.00 ➝ $104.00	N/A	i
10/2/2016	SVB Leerink	Reiterated Rating	Outperform	$110.00 ➝ $105.00	N/A	i Rating by David Larsen at SVB Leerink LLC
9/30/2016	Mizuho	Reiterated Rating	Buy	$111.00	N/A	i Rating by Ann Hynes at Mizuho
9/20/2016	Credit Suisse Group	Reiterated Rating	Buy	$115.00	N/A	i Rating by Robert Willoughby at Credit Suisse Group AG
9/12/2016	Morgan Stanley	Reiterated Rating	Hold	$104.00	N/A	i Rating by Ricky Goldwasser at Morgan Stanley
8/8/2016	Citigroup	Lower Price Target	Neutral	$115.00 ➝ $108.00	N/A	i
8/4/2016	Argus	Reiterated Rating	Buy	$120.00	N/A	i
8/4/2016	Mizuho	Boost Price Target	Buy	$108.00 ➝ $111.00	N/A	i Rating by Ann Hynes at Mizuho
8/3/2016	SVB Leerink	Reiterated Rating	Buy		N/A	i Rating by David Larsen at SVB Leerink LLC
8/3/2016	Morgan Stanley	Reiterated Rating	Hold	$104.00	N/A	i Rating by Ricky Goldwasser at Morgan Stanley
8/3/2016	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$99.00 ➝ $108.00	N/A	i Rating by George Hill at Deutsche Bank Aktiengesellschaft
8/3/2016	(FBRC)	Reiterated Rating	Outperform	$120.00	N/A	i Rating by Steven Halper at (FBRC)
7/4/2016	Jefferies Financial Group	Reiterated Rating	Buy		N/A	i Rating by Mark Wiltamuth at Jefferies Financial Group Inc.
6/23/2016	Mizuho	Reiterated Rating	Buy	$117.00 ➝ $108.00	N/A	i Rating by Ann Hynes at Mizuho
6/22/2016	Deutsche Bank Aktiengesellschaft	Boost Price Target	Hold	$99.00 ➝ $105.00	N/A	i Rating by George Hill at Deutsche Bank Aktiengesellschaft
6/20/2016	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$111.00 ➝ $104.00	N/A	i Rating by Ricky Goldwasser at Morgan Stanley
6/10/2016	SVB Leerink	Reiterated Rating	Buy		N/A	i Rating by David Larsen at SVB Leerink LLC
6/5/2016	Credit Suisse Group	Reiterated Rating	Buy	$115.00	N/A	i
5/14/2016	(FBRC)	Reiterated Rating	Buy		N/A	i Rating by Steven Halper at (FBRC)
5/12/2016	Jefferies Financial Group	Boost Price Target	Buy	$110.00 ➝ $122.00	N/A	i
5/9/2016	Citigroup	Boost Price Target	Neutral	$105.00 ➝ $115.00	N/A	i Rating by Alvin Concepcion at Citigroup Inc.

(Data available from 5/9/2016 forward)

CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail order, mail order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. Its Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December 31, 2020, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Today's Range

Now: $85.11

$83.71

$85.35

50 Day Range

MA: $75.53

$71.90

$83.70

52 Week Range

Now: $85.11

$55.36

$85.35

Volume

8,206,262 shs

Average Volume

6,982,176 shs

Market Capitalization

$112.05 billion

P/E Ratio

14.07

Dividend Yield

2.39%

Beta

0.82

Frequently Asked Questions

What sell-side analysts currently cover shares of CVS Health?

The following Wall Street analysts have issued stock ratings on CVS Health in the last twelve months: BMO Capital Markets, Cantor Fitzgerald, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Guggenheim, Jefferies Financial Group Inc., Morgan Stanley, Piper Sandler, Raymond James, Royal Bank of Canada, SVB Leerink LLC, Truist, and Truist Securities.
View the latest analyst ratings for CVS.

What is the current price target for CVS Health?

13 Wall Street analysts have set twelve-month price targets for CVS Health in the last year. Their average twelve-month price target is $91.69, suggesting a possible upside of 7.7%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting CVS will reach $101.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $76.00 for CVS Health in the next year.
View the latest price targets for CVS.

What is the current consensus analyst rating for CVS Health?

CVS Health currently has 3 hold ratings, 8 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CVS will outperform the market and that investors should add to their positions of CVS Health.
View the latest ratings for CVS.

What other companies compete with CVS Health?

Other companies that are similar to CVS Health include Walgreens Boots Alliance, Covetrus, Rite Aid, 111, PetMed Express, Progressive Care, China Jo-Jo Drugstores, HealthWarehouse.com, Dragon Jade International, Dougherty's Pharmacy, China Dasheng Biotechnology and Health Sciences Group.

How do I contact CVS Health's investor relations team?

CVS Health's physical mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator's listed phone number is 401-765-1500 and its investor relations email address is [email protected] The official website for CVS Health is www.cvshealth.com.